TAKE · Healthcare · Health Information Services
| Share price | ₹19.98 |
| Market cap | ₹292 Cr |
| P/E ratio | 68.9 |
| P/B ratio | 9.7 |
| ROE | 73.4% |
| ROCE | 15.4% |
| Book value | ₹2.06 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹54 Cr | ₹11 Cr | -3.5% |
| 2025 | ₹0 Cr | ₹37 Cr | — |
| 2024 | ₹4 Cr | ₹-120 Cr | -181.0% |
| 2023 | ₹189 Cr | ₹-100 Cr | 3.1% |
| 2022 | — | — | — |
TAKE LIMITED, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personal